GERD and obesity

Authors: Scarpellini, E; Tack, J

Source journal: Best practice & research. Clinical gastroenterology (2026-09-01)

DOI: 10.1016/j.bpg.2026.102166

Abstract

BACKGROUND: Gastroesophageal reflux disease (GERD) is a gastrointestinal disorder associated with an increased risk of esophagitis, esophageal strictures, Barrett esophagus and esophageal adenocarcinoma. According to several epidemiological studies excess obesity and central visceral adiposity can be risk factors for GERD. METHODS: We performed a narrative review of literature evidence on the nutritional approach to dumping syndrome. In detail, we made a search on main medical databases for publications using the following keywords, their acronyms and their associations (e.g., "and "): "obesity"," GERD", "Barrett esophagus ", "esophageal adenocarcinoma ", "bariatric surgery", "glucagon like peptides agonists". RESULTS: Obesity and, more specifically central adiposity are risk factors for GERD and its complications. Novel incretin drugs' use can be associated, especially in the short period, with GERD. Reflux surgery and, also bariatric surgery can be associated at various degree with GERD and its complications' occurrence/recurrence in obese subjects. A personalized GERD treatment flow-chart is proposed for its management in obese patients. CONCLUSIONS: obesity and central adiposity are associated with GERD. Pharmacological and surgical treatment for obesity and, also anti-reflux surgery for GERD, can be associated with reflux occurrence/recurrence.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.